The frequency of common EGFR mutation in adenocarcinoma, which depends on the patients’ background, ranges from 15 to 45%, suggesting that the common EGFR mutation is a frequent and important event of lung adenocarcinomas [11, 13, 14]. The gene discussed is EGFR; the disease is lung adenocarcinoma.